The Ser358Leu mutation of transmembrane protein 43 (TMEM43) was commonly identified in the patients of highly lethal and fully penetrant ARVD subtype, ARVD5. The gene discussed is TMEM43; the disease is arrhythmogenic right ventricular cardiomyopathy.